Patents by Inventor Jeffrey Khoo

Jeffrey Khoo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Terameprocol and nordihydroguaiaretic acid (NDGA) derivatives as coronavirus anti-viral agents
    Patent number: 11844768
    Abstract: Nordihydroguaiaretic acid (NDGA) derivatives, including terameprocol (TMP) have utility as anti-viral agents for use on patients infected with or at risk of infection with a coronavirus, including SARS-CoV-2. In vitro studies show coronavirus-infected cells treated with 0.2 ?M-20 ?M TMP show reduced viral RNA activity in vitro. Treatment-related cytotoxicity is not shown at 0.2 ?M TMP with a low percentage of cytotoxicity shown at 5 ?M TMP. In application, the NDGA derivatives may be administered to a patient intravenously at a molar concentration of 0.1-50 ?M or orally at a molar concentration of 0.1-100 ?M.
    Type: Grant
    Filed: January 14, 2022
    Date of Patent: December 19, 2023
    Assignee: Erimos Pharmaceuticals, LLC
    Inventors: Jeffrey Khoo, Stephan D. Glenn
  • TERAMEPROCOL AND NORDIHYDROGUAIARETIC ACID (NDGA) DERIVATIVES AS CORONAVIRUS ANTI-VIRAL AGENTS
    Publication number: 20220233466
    Abstract: Nordihydroguaiaretic acid (NDGA) derivatives, including terameprocol (TMP) have utility as anti-viral agents for use on patients infected with or at risk of infection with a coronavirus, including SARS-CoV-2. In vitro studies show coronavirus-infected cells treated with 0.2 ?M-20 ?M TMP show reduced viral RNA activity in vitro. Treatment-related cytotoxicity is not shown at 0.2 ?M TMP with a low percentage of cytotoxicity shown at 5 ?M TMP. In application, the NDGA derivatives may be administered to a patient intravenously at a molar concentration of 0.1-50 ?M or orally at a molar concentration of 0.1-100 ?M.
    Type: Application
    Filed: January 14, 2022
    Publication date: July 28, 2022
    Inventors: Jeffrey Khoo, Stephan D. Glenn
  • Mixtures of triglycerides and of alkylesters from vegetable oil and applications
    Patent number: 11254891
    Abstract: A mixture of alkylesters of fatty acids is provided, wherein the fatty acids have the following composition: at least 56% of saturated C12 chains, at least 23% of saturated C14 chains, at most 8% of saturated C16 chains, at most 5% of saturated C6-10 chains, at most 5% of monounsaturated C18 chains, at most 2% of saturated C18 chains, at most 0.8% of diunsaturated C18 chains, and at most 0.2% of saturated C20 chains. The percentages are an average percentage expressed in number of moles per total number of moles of alkylesters, and the use of these mixtures is as a viscosity agent.
    Type: Grant
    Filed: February 1, 2019
    Date of Patent: February 22, 2022
    Assignee: BIOBOON LIMITED
    Inventors: Jeffrey Khoo Meng Chuan, Laurent Richard Charles Dumortier
  • MIXTURES OF TRIGLYCERIDES AND OF ALKYLESTERS FROM VEGETABLE OIL AND APPLICATIONS
    Publication number: 20210040410
    Abstract: A mixture of alkylesters of fatty acids is provided, wherein the fatty acids have the following composition: at least 56% of saturated C12 chains, at least 23% of saturated C14 chains, at most 8% of saturated C16 chains, at most 5% of saturated C6-10 chains, at most 5% of monounsaturated C18 chains, at most 2% of saturated C18 chains, at most 0.8% of diunsaturated C18 chains, and at most 0.2% of saturated C20 chains. The percentages are an average percentage expressed in number of moles per total number of moles of alkylesters, and the use of these mixtures is as a viscosity agent.
    Type: Application
    Filed: February 1, 2019
    Publication date: February 11, 2021
    Inventors: Jeffrey KHOO MENG CHUAN, Laurent Richard Charles DUMORTIER